Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1719

1.

Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Nakashima T, Liu T, Hu B, Wu Z, Ullenbruch M, Omori K, Ding L, Hattori N, Phan SH.

Am J Respir Crit Care Med. 2019 May 18. doi: 10.1164/rccm.201808-1560OC. [Epub ahead of print]

PMID:
31106564
2.

Severe metastatic pulmonary calcification.

Taniwaki M, Kawamoto K, Yamasaki M, Kunihiko Funaishi MD, Yu Matsumoto MD, Naoko Matsumoto MD, Ohashi N, Hattori N.

Am J Med. 2019 May 14. pii: S0002-9343(19)30417-6. doi: 10.1016/j.amjmed.2019.04.031. [Epub ahead of print] No abstract available.

PMID:
31100282
3.

Increased lysosomal exocytosis induced by lysosomal Ca2+ channel agonists protects human dopaminergic neurons from α-synuclein toxicity.

Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, Krishna Vangipuram Suresh M, Wong YC, Xie Z, Akamatsu W, Mazzulli JR, Surmeier DJ, Hattori N, Krainc D.

J Neurosci. 2019 May 16. pii: 3085-18. doi: 10.1523/JNEUROSCI.3085-18.2019. [Epub ahead of print]

PMID:
31097622
4.

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T.

Gut. 2019 May 13. pii: gutjnl-2018-317645. doi: 10.1136/gutjnl-2018-317645. [Epub ahead of print]

PMID:
31085554
5.

Organization of functional modularity in sitting balance response and gait performance after stroke.

Yamasaki HR, An Q, Kinomoto M, Takahashi K, Fujii T, Kogami H, Yang N, Yamakawa H, Tamura Y, Itkonen M, Sonoo M, Alnajjar FSK, Yamashita A, Otomune H, Hattori N, Asama H, Miyai I, Shimoda S.

Clin Biomech (Bristol, Avon). 2019 May 3;67:61-69. doi: 10.1016/j.clinbiomech.2019.04.022. [Epub ahead of print]

PMID:
31075736
6.

Iron supply via NCOA4-mediated ferritin degradation maintains mitochondrial functions.

Fujimaki M, Furuya N, Saiki S, Amo T, Imamichi Y, Hattori N.

Mol Cell Biol. 2019 May 6. pii: MCB.00010-19. doi: 10.1128/MCB.00010-19. [Epub ahead of print]

PMID:
31061094
7.

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N.

J Neurol. 2019 May 2. doi: 10.1007/s00415-019-09347-4. [Epub ahead of print]

PMID:
31049728
8.

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2019 Apr 30. doi: 10.1097/WNF.0000000000000343. [Epub ahead of print]

PMID:
31045589
9.

Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism.

Nakayama S, Shimonaka S, Elahi M, Nishioka K, Oji Y, Matsumoto SE, Li Y, Yoshino H, Mogushi K, Hatano T, Sato T, Ikura T, Ito N, Motoi Y, Hattori N.

Neurobiol Aging. 2019 Mar 1. pii: S0197-4580(19)30066-1. doi: 10.1016/j.neurobiolaging.2019.02.016. [Epub ahead of print]

PMID:
31027853
10.
11.

Three-Component Repurposed Technology for Enhanced Expression: Highly Accumulable Transcriptional Activators via Branched Tag Arrays.

Kunii A, Hara Y, Takenaga M, Hattori N, Fukazawa T, Ushijima T, Yamamoto T, Sakuma T.

CRISPR J. 2018 Oct;1:337-347. doi: 10.1089/crispr.2018.0009.

PMID:
31021277
12.

Photochemical generation of the 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) radical from caged nitroxides by near-infrared two-photon irradiation and its cytocidal effect on lung cancer cells.

Yamada A, Abe M, Nishimura Y, Ishizaka S, Namba M, Nakashima T, Shimoji K, Hattori N.

Beilstein J Org Chem. 2019 Apr 10;15:863-873. doi: 10.3762/bjoc.15.84. eCollection 2019.

13.

Corticosteroid therapy for organizing pneumonia in a human T-cell lymphotropic virus type-1 carrier.

Taniwaki M, Yamasaki M, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Pulmonology. 2019 Apr 15. pii: S2531-0437(19)30033-9. doi: 10.1016/j.pulmoe.2019.02.004. [Epub ahead of print] No abstract available.

14.

Involvement of cortical dysfunction in frequent falls in patients with Parkinson's disease.

Otomune H, Mihara M, Hattori N, Fujimoto H, Kajiyama Y, Konaka K, Mitani Y, Watanabe Y, Mochizuki H.

Parkinsonism Relat Disord. 2019 Apr 11. pii: S1353-8020(19)30202-0. doi: 10.1016/j.parkreldis.2019.04.007. [Epub ahead of print]

PMID:
30992233
15.

Bilateral thigh compartment syndromes from extended sitting with forward bending.

Shimada T, Tsunemi T, Hattori A, Nakazato-Taniguchi T, Yasuhara H, Ogaki K, Hattori N.

J Clin Neurosci. 2019 Apr 6. pii: S0967-5868(19)30213-9. doi: 10.1016/j.jocn.2019.03.027. [Epub ahead of print]

PMID:
30967313
16.

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease.

Valentine MNZ, Hashimoto K, Fukuhara T, Saiki S, Ishikawa KI, Hattori N, Carninci P.

Sci Data. 2019 Apr 5;6(1):20. doi: 10.1038/s41597-019-0022-9.

17.

Postural Abnormality in Parkinson's Disease: A Large Comparative Study With General Population.

Ando Y, Fujimoto KI, Ikeda K, Utsumi H, Okuma Y, Oka H, Kamei S, Kurita A, Takahashi K, Nogawa S, Hattori N, Hirata K, Fukui T, Yamazaki K, Yamamoto T, Yoshii F.

Mov Disord Clin Pract. 2019 Jan 25;6(3):213-221. doi: 10.1002/mdc3.12723. eCollection 2019 Mar.

PMID:
30949552
18.

Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress.

Izumi Y, Nakashima T, Masuda T, Shioya S, Fukuhara K, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Free Radic Biol Med. 2019 May 20;136:52-59. doi: 10.1016/j.freeradbiomed.2019.03.024. Epub 2019 Mar 28.

PMID:
30930296
19.

Large aortic arch plaques correlate with CHADS2 and CHA2DS2-VASc scores in cryptogenic stroke.

Ueno Y, Tateishi Y, Doijiri R, Kuriki A, Shimizu T, Kikuno M, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Hattori N, Urabe T.

Atherosclerosis. 2019 May;284:181-186. doi: 10.1016/j.atherosclerosis.2019.03.009. Epub 2019 Mar 20.

PMID:
30921601
20.

LINC00162 confers sensitivity to 5-Aza-2'-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1.

Zong L, Hattori N, Yasukawa Y, Kimura K, Mori A, Seto Y, Ushijima T.

Oncogene. 2019 Mar 26. doi: 10.1038/s41388-019-0792-8. [Epub ahead of print]

PMID:
30914798
21.

Metabolomics-based identification of metabolic alterations in PARK2.

Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N.

Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536. doi: 10.1002/acn3.724. eCollection 2019 Mar.

22.

Alteration of gut microbiota by a Westernized lifestyle and its correlation with insulin resistance in non-diabetic Japanese men.

Yamashita M, Okubo H, Kobuke K, Ohno H, Oki K, Yoneda M, Tanaka J, Hattori N.

J Diabetes Investig. 2019 Mar 22. doi: 10.1111/jdi.13048. [Epub ahead of print]

23.

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report.

Nakao S, Masuda T, Sakamoto S, Yamaguchi K, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Medicine (Baltimore). 2019 Mar;98(12):e14821. doi: 10.1097/MD.0000000000014821.

24.

Endobronchial mucosa-associated lymphoid tissue (MALT) lymphoma.

Yamasaki M, Funaishi K, Muta T, Matsumoto N, Taniwaki M, Hattori N.

QJM. 2019 Mar 21. pii: hcz069. doi: 10.1093/qjmed/hcz069. [Epub ahead of print] No abstract available.

PMID:
30895318
25.

The Effects of Astrocyte and Oligodendrocyte Lineage Cell Interaction on White Matter Injury under Chronic Cerebral Hypoperfusion.

Magami S, Miyamoto N, Ueno Y, Hira K, Tanaka R, Yamashiro K, Oishi H, Arai H, Urabe T, Hattori N.

Neuroscience. 2019 May 15;406:167-175. doi: 10.1016/j.neuroscience.2019.03.004. Epub 2019 Mar 10.

PMID:
30867131
26.

Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.

Arai N, Homma M, Abe M, Baba Y, Murai S, Watanuki M, Kawaguchi Y, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Saito B, Shiozawa E, Harada H, Yamochi-Onizuka T, Nakamaki T, Takimoto M.

Int J Hematol. 2019 May;109(5):539-544. doi: 10.1007/s12185-019-02616-y. Epub 2019 Mar 7.

PMID:
30847774
27.

Parkinsonism relating to intoxication with glyphosate: A case report.

Eriguchi M, Iida K, Ikeda S, Osoegawa M, Nishioka K, Hattori N, Nagayama H, Hara H.

Intern Med. 2019 Feb 25. doi: 10.2169/internalmedicine.2028-18. [Epub ahead of print]

28.

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Imai Y, Meng H, Shiba-Fukushima K, Hattori N.

Int J Mol Sci. 2019 Feb 20;20(4). pii: E908. doi: 10.3390/ijms20040908. Review.

29.

Establishing extracorporeal membrane oxygenation team increased number of patients and improved data recording.

Komindr A, Abe R, Tateishi Y, Takahashi Y, Goto J, Wada K, Furukawa Y, Sugiura A, Imaeda T, Suga N, Hattori N, Oda S.

J Intensive Care. 2019 Feb 7;7:11. doi: 10.1186/s40560-019-0366-4. eCollection 2019.

30.

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.

Ikeda A, Shimada H, Nishioka K, Takanashi M, Hayashida A, Li Y, Yoshino H, Funayama M, Ueno Y, Hatano T, Sahara N, Suhara T, Higuchi M, Hattori N.

Mov Disord. 2019 Apr;34(4):568-574. doi: 10.1002/mds.27623. Epub 2019 Feb 17.

PMID:
30773680
31.

Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.

Kamo H, Ueno Y, Sugiyama M, Miyamoto N, Yamashiro K, Tanaka R, Yokoyama K, Hattori N.

J Neuroimmunol. 2019 May 15;330:19-22. doi: 10.1016/j.jneuroim.2019.01.020. Epub 2019 Feb 1.

PMID:
30769213
32.

Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.

Taniwaki M, Katsutani S, Yamasaki M, Kawamoto K, Funaishi K, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Ann Hematol. 2019 Feb 12. doi: 10.1007/s00277-019-03638-6. [Epub ahead of print] No abstract available.

PMID:
30747247
33.

Adjuvant and antigenic properties of Mycobacterium avium subsp. paratuberculosis on experimental autoimmune encephalomyelitis.

Cossu D, Yokoyama K, Sakanishi T, Momotani E, Hattori N.

J Neuroimmunol. 2019 May 15;330:174-177. doi: 10.1016/j.jneuroim.2019.01.013. Epub 2019 Jan 23.

PMID:
30738572
34.

Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.

Masuda T, Nakashima T, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Miyata Y, Hamada H, Okada M, Hattori N.

J Cell Mol Med. 2019 Apr;23(4):2984-2994. doi: 10.1111/jcmm.14205. Epub 2019 Feb 7.

35.

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases.

Yamasaki M, Daido W, Saito N, Funaishi K, Okada T, Kawamoto K, Matsumoto Y, Matsumoto N, Taniwaki M, Ohashi N, Hattori N.

Front Oncol. 2019 Jan 22;9:4. doi: 10.3389/fonc.2019.00004. eCollection 2019.

36.

A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson's Disease.

Sekimoto S, Oyama G, Hatano T, Sasaki F, Nakamura R, Jo T, Shimo Y, Hattori N.

Parkinsons Dis. 2019 Jan 6;2019:9403295. doi: 10.1155/2019/9403295. eCollection 2019.

37.

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.

Takao S, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Medicine (Baltimore). 2019 Feb;98(5):e14296. doi: 10.1097/MD.0000000000014296.

38.

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma.

Sonohara F, Yamada S, Tanaka N, Suenaga M, Takami H, Hayashi M, Niwa Y, Sugimoto H, Hattori N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Ann Gastroenterol Surg. 2018 Sep 27;3(1):65-74. doi: 10.1002/ags3.12212. eCollection 2019 Jan.

39.

An Essential Role of the Intraparietal Sulcus in Response Inhibition Predicted by Parcellation-Based Network.

Osada T, Ohta S, Ogawa A, Tanaka M, Suda A, Kamagata K, Hori M, Aoki S, Shimo Y, Hattori N, Shimizu T, Enomoto H, Hanajima R, Ugawa Y, Konishi S.

J Neurosci. 2019 Mar 27;39(13):2509-2521. doi: 10.1523/JNEUROSCI.2244-18.2019. Epub 2019 Jan 28.

PMID:
30692225
40.

Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease.

Hattori N, Takeda A, Takeda S, Nishimura A, Kitagawa T, Mochizuki H, Nagai M, Takahashi R.

J Neural Transm (Vienna). 2019 Mar;126(3):299-308. doi: 10.1007/s00702-018-1964-3. Epub 2019 Jan 28.

41.

Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.

Kawamura M, Sato S, Matsumoto G, Fukuda T, Shiba-Fukushima K, Noda S, Takanashi M, Mori N, Hattori N.

Neurosci Lett. 2019 Apr 23;699:59-63. doi: 10.1016/j.neulet.2019.01.042. Epub 2019 Jan 23.

42.

Associations of nutrient intakes with obesity and diabetes mellitus in the longitudinal medical surveys of Japanese Americans.

Sugihiro T, Yoneda M, Ohno H, Oki K, Hattori N.

J Diabetes Investig. 2019 Jan 21. doi: 10.1111/jdi.13010. [Epub ahead of print]

43.

Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations.

Iwasawa C, Kuzumaki N, Suda Y, Kagawa R, Oka Y, Hattori N, Okano H, Narita M.

Mol Brain. 2019 Jan 18;12(1):5. doi: 10.1186/s13041-019-0426-7.

44.

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Kita T, Hiraoka N, Ishizuka T, Kubota Y, Kawasaki M, Goto Y, Imai H, Hattori N, Nakatomi K, Uramoto H, Uryu K, Fukuda M, Uchida Y, Yokoyama T, Akai M, Mio T, Nagashima S, Chihara Y, Tamiya N, Kaneko Y, Mouri T, Yamada T, Yoshimura K, Fujita M, Takayama K.

Oncologist. 2019 May;24(5):593-e170. doi: 10.1634/theoncologist.2019-0003. Epub 2019 Jan 16.

PMID:
30651400
45.

Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.

Hattori N, Kawaguchi Y, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Saito B, Harada H, Nakamaki T.

Biol Blood Marrow Transplant. 2019 May;25(5):861-867. doi: 10.1016/j.bbmt.2019.01.013. Epub 2019 Jan 11.

PMID:
30639819
46.

Giant Fecaloma Causing Anorexia and Dysuria.

Yamasaki M, Funaishi K, Hattori N.

Clin Gastroenterol Hepatol. 2019 Jan 11. pii: S1542-3565(19)30024-2. doi: 10.1016/j.cgh.2019.01.004. [Epub ahead of print] No abstract available.

PMID:
30639776
47.

Painful legs and moving toes syndrome evaluated through brain single photon emission computed tomography: a case series.

Nishioka K, Suzuki M, Nakajima M, Hara T, Iseki M, Hattori N.

J Neurol. 2019 Mar;266(3):717-725. doi: 10.1007/s00415-019-09194-3. Epub 2019 Jan 14.

PMID:
30637456
48.

Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson's disease.

Hattori N, Takeda A, Takeda S, Nishimura A, Nakaya R, Mochizuki H, Nagai M, Takahashi R.

J Neural Transm (Vienna). 2019 Mar;126(3):289-297. doi: 10.1007/s00702-018-1962-5. Epub 2019 Jan 11.

49.

Improving the Quality of Synthetic FLAIR Images with Deep Learning Using a Conditional Generative Adversarial Network for Pixel-by-Pixel Image Translation.

Hagiwara A, Otsuka Y, Hori M, Tachibana Y, Yokoyama K, Fujita S, Andica C, Kamagata K, Irie R, Koshino S, Maekawa T, Chougar L, Wada A, Takemura MY, Hattori N, Aoki S.

AJNR Am J Neuroradiol. 2019 Feb;40(2):224-230. doi: 10.3174/ajnr.A5927. Epub 2019 Jan 10.

PMID:
30630834
50.

A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism.

Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ; SNCA Multiplication Investigators of the GEoPD Consortium.

Front Neurol. 2018 Dec 11;9:1021. doi: 10.3389/fneur.2018.01021. eCollection 2018.

Supplemental Content

Loading ...
Support Center